Anti-PD-L1 antibodies and their use to enhance T-cell function

Details for Australian Patent Application No. 2009333580 (hide)

Owner GENENTECH, INC.

Inventors Irving, Bryan; Cheung, Jeanne; Chiu, Henry; Lehar, Sophie M.; Maecker, Heather; Mariathasan, Sanjeev; Wu, Yan

Agent Griffith Hack

Pub. Number AU-A-2009333580

PCT Pub. Number WO2010/077634

Priority 61/121,092 09.12.08 US

Filing date 8 December 2009

Wipo publication date 8 July 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/077634 Priority application(s): WO2010/077634

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009333588-Method of modulating HSF-1

2009333576-Lubricating composition containing a compound derived from a hydroxycarboxylic acid